vs
Side-by-side financial comparison of HCI Group, Inc. (HCI) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
HCI Group, Inc. is the larger business by last-quarter revenue ($242.9M vs $151.7M, roughly 1.6× Nutex Health, Inc.). HCI Group, Inc. runs the higher net margin — 35.0% vs 7.8%, a 27.2% gap on every dollar of revenue. On growth, HCI Group, Inc. posted the faster year-over-year revenue change (12.2% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 8.5%).
HCI Equity Partners is a Washington, DC–based private equity firm with an additional office in Chicago, Illinois.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
HCI vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $242.9M | $151.7M |
| Net Profit | $85.0M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 35.0% | 7.8% |
| Revenue YoY | 12.2% | -41.1% |
| Net Profit YoY | 14.6% | -80.8% |
| EPS (diluted) | $5.45 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $242.9M | — | ||
| Q4 25 | $246.2M | $151.7M | ||
| Q3 25 | $216.3M | $267.8M | ||
| Q2 25 | $221.9M | $244.0M | ||
| Q1 25 | $216.4M | $211.8M | ||
| Q4 24 | $161.9M | $257.6M | ||
| Q3 24 | $175.3M | $78.8M | ||
| Q2 24 | $206.2M | $76.1M |
| Q1 26 | $85.0M | — | ||
| Q4 25 | $97.7M | $11.8M | ||
| Q3 25 | $65.5M | $55.4M | ||
| Q2 25 | $66.2M | $-17.7M | ||
| Q1 25 | $69.7M | $21.2M | ||
| Q4 24 | $2.6M | $61.6M | ||
| Q3 24 | $5.7M | $-8.8M | ||
| Q2 24 | $54.1M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | — | — | ||
| Q4 25 | 58.5% | 20.4% | ||
| Q3 25 | 41.9% | 48.7% | ||
| Q2 25 | 42.5% | 13.8% | ||
| Q1 25 | 46.4% | 38.1% | ||
| Q4 24 | 3.6% | 44.4% | ||
| Q3 24 | 8.0% | 12.3% | ||
| Q2 24 | 36.9% | 7.0% |
| Q1 26 | 35.0% | — | ||
| Q4 25 | 39.7% | 7.8% | ||
| Q3 25 | 30.3% | 20.7% | ||
| Q2 25 | 29.8% | -7.3% | ||
| Q1 25 | 32.2% | 10.0% | ||
| Q4 24 | 1.6% | 23.9% | ||
| Q3 24 | 3.2% | -11.2% | ||
| Q2 24 | 26.2% | -0.5% |
| Q1 26 | $5.45 | — | ||
| Q4 25 | $7.29 | $2.34 | ||
| Q3 25 | $4.90 | $7.76 | ||
| Q2 25 | $5.18 | $-2.95 | ||
| Q1 25 | $5.35 | $3.33 | ||
| Q4 24 | $0.32 | $11.56 | ||
| Q3 24 | $0.52 | $-1.72 | ||
| Q2 24 | $4.24 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $185.6M |
| Total DebtLower is stronger | $31.7M | — |
| Stockholders' EquityBook value | $1.1B | $329.4M |
| Total Assets | $2.6B | $918.5M |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $185.6M | ||
| Q3 25 | $987.9M | $166.0M | ||
| Q2 25 | $947.2M | $96.7M | ||
| Q1 25 | $754.5M | $84.7M | ||
| Q4 24 | $532.5M | $40.6M | ||
| Q3 24 | $518.8M | $46.9M | ||
| Q2 24 | $445.8M | $40.8M |
| Q1 26 | $31.7M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.0B | $329.4M | ||
| Q3 25 | $821.8M | $317.2M | ||
| Q2 25 | $758.6M | $235.3M | ||
| Q1 25 | $522.7M | $176.9M | ||
| Q4 24 | $453.3M | $132.4M | ||
| Q3 24 | $455.3M | $60.4M | ||
| Q2 24 | $447.3M | $62.7M |
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.5B | $918.5M | ||
| Q3 25 | $2.3B | $964.5M | ||
| Q2 25 | $2.4B | $841.0M | ||
| Q1 25 | $2.3B | $761.9M | ||
| Q4 24 | $2.2B | $655.3M | ||
| Q3 24 | $2.0B | $438.5M | ||
| Q2 24 | $1.9B | $422.4M |
| Q1 26 | 0.03× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $444.4M | $70.4M | ||
| Q3 25 | $26.7M | $99.5M | ||
| Q2 25 | $145.0M | $27.3M | ||
| Q1 25 | $162.0M | $51.0M | ||
| Q4 24 | $331.8M | $54.0K | ||
| Q3 24 | $104.1M | $6.8M | ||
| Q2 24 | $-29.0M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $440.8M | $69.0M | ||
| Q3 25 | $25.9M | $99.2M | ||
| Q2 25 | $144.5M | $26.5M | ||
| Q1 25 | $160.3M | $50.9M | ||
| Q4 24 | $327.8M | $-341.0K | ||
| Q3 24 | $103.2M | $6.2M | ||
| Q2 24 | $-30.1M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | 179.0% | 45.5% | ||
| Q3 25 | 12.0% | 37.0% | ||
| Q2 25 | 65.1% | 10.9% | ||
| Q1 25 | 74.1% | 24.0% | ||
| Q4 24 | 202.5% | -0.1% | ||
| Q3 24 | 58.9% | 7.8% | ||
| Q2 24 | -14.6% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.5% | 0.9% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.8% | 0.0% | ||
| Q4 24 | 2.5% | 0.2% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.5% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.55× | 5.95× | ||
| Q3 25 | 0.41× | 1.80× | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 2.32× | 2.40× | ||
| Q4 24 | 128.41× | 0.00× | ||
| Q3 24 | 18.33× | — | ||
| Q2 24 | -0.54× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCI
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |